Biopharm Drug Substance Development is a highly experienced Chemistry, Manufacturing and Controls (CMC) organization accountable for delivering robust, cost-effective and competitive products and manufacturing processes spanning the full lifecycle of asset development from the pre-clinical stage through commercialization. These activities are delivered through state-of-the-art internal facilities and strategic external partners. Collectively, the team is accountable for CMC activities encompassing cell line support, cell culture/microbial fermentation, and purification development. We also pioneer innovative technologies to improve the process robustness, productivity, and to reduce the cost of goods.
The Biopharm Drug Substance Development group is searching for a Process Development Co-op to join a high-performing team of upstream scientists who are working to scale and optimize processes related to intensified perfusion cell cultures. This role will be predominantly lab-based and will require skills relating to experimental design/execution, process scaling, cell culture, performing laboratory assays, data analysis, and report writing. Specifically, you will have the opportunity to perform calculations related to the scaling of intensified N-1 perfusion bioreactor systems, culture mammalian cells to high densities using cell retention devices in small-scale bioreactors, and to analyze the cellular health and productivity. This co-op is designed to provide experience in an exciting and valuable area of biopharmaceutical manufacturing.
Interested in learning more? Register now on our digital learning platform (GSK Get Ahead - Connectr) where you can access interview and assessment hints and tips, speak to a mentor and learn more about life at GSK.
Software Powered by iCIMS
www.icims.com